The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Northern and Western areas keep best of sunshine in next few days.
Eduardo Paes says that despite Brazil's political turmoil Rio de Janeiro is ready to welcome the world for the 2016 Games.
France will host the tournament from June 10 to July 10, with hundreds of thousands of fans set to flock to the country.